Drug intelligence / Profile preview

lavior

Development stage
Unknown
Lead developer
Lavior Pharma
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Lavior is an over-the-counter topical wound gel primarily intended for the treatment and management of diabetic wounds, including foot and leg ulcers. Its key active ingredient is allantoin (1% concentration), which acts as a skin protectant to promote wound healing and relieve dry, chafed, chapped, or cracked skin. The product is formulated with botanically derived and synthetic ingredients (including Inula viscosa extract, hyaluronate sodium, tocopheryl acetate/Vitamin E, etc.), designed to create and maintain a moist wound environment, facilitate autolytic debridement, and support the body’s natural repair processes. Lavior is hypoallergenic and specifically formulated for sensitive and diabetic skin. It is marketed by Lavior Pharma as a gentle and safe solution, endorsed by clinical trials and the American Diabetes Association for effective wound care[2][3][4][6].

Brand names
Lavior
Other names
Lavior Diabetic Wound GelLavior Diabetic HydrogelDiabetic Wound Gel

Beyond the preview

Go deeper on lavior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lavior.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call